Source recordFED

Nicoya Lifesciences Inc.

Federal grants & contributions· Innovative Solutions Canada· National Research Council Canada· FY2021· $2,000,000· BN 745547281· ON

Description

The Public Health Agency of Canada (PHAC) and National Research Council (NRC) are seeking a solution that will diagnose individuals affected by COVID-19 within 3 days of the start of their symptoms using a sample, other than a nasopharyngea…

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$2,000,000$0Original · 2021-01-04 (start date) · total $2,000,000
  • #02021-01-04$2,000,000
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2021-01-04(start date)$2,000,000—The Public Health Agency of Canada (PHAC) and National Research Council (NRC) are seeking a solution that will…

Related records · 5

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other recipients funded under "Innovative Solutions Canada" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q4-1040606TerraFixing Inc.FY2026$1,500,000FY2026
172-2025-2026-Q4-104060515138671 Canada Inc.FY2026$1,500,000FY2026
172-2024-2025-Q4-1038928VEI Contracting Inc.FY2026$1,498,000FY2026
172-2025-2026-Q2-103381015138671 Canada Inc.FY2026$198,905FY2026
172-2025-2026-Q2-103405612989972 Canada inc.FY2026$200,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2020-2021-Q4 - 962045 · retrieved 2026-11-14.